诚意药业
(603811)
| 流通市值：38.82亿 | | | 总市值：38.82亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 268,783,691.37 | 220,703,850.99 | 205,125,531.51 | 198,670,494.92 |
| 应收票据及应收账款 | 42,027,339.88 | 22,580,501.94 | 38,689,631.8 | 43,667,028.01 |
| 应收账款 | 42,027,339.88 | 22,580,501.94 | 38,689,631.8 | 43,667,028.01 |
| 应收款项融资 | 17,889,911.43 | 16,379,646.23 | 8,267,515.57 | 31,597,659.33 |
| 预付款项 | 13,747,736.3 | 15,539,056.8 | 7,293,958.41 | 7,792,498.5 |
| 其他应收款合计 | 1,763,664.7 | 1,560,113.19 | 2,097,975.28 | 2,008,909.75 |
| 存货 | 116,716,383.27 | 116,341,994.19 | 125,324,247.36 | 104,746,481.72 |
| 其他流动资产 | 3,383,447.24 | 2,161,094.8 | 570,576.59 | 240,922.68 |
| 流动资产合计 | 464,312,174.19 | 395,491,049.41 | 396,179,491.32 | 388,948,786.18 |
| 非流动资产: | | | | |
| 长期股权投资 | 340,500,984.81 | 336,721,047.61 | 331,720,790.68 | 323,651,971.73 |
| 投资性房地产 | 840,605.62 | 870,631.09 | 900,656.56 | 930,682.03 |
| 固定资产 | 839,550,324.3 | 860,523,471.5 | 883,529,252.79 | 901,493,283.82 |
| 在建工程 | 52,599,145.51 | 30,705,137.4 | 11,162,572.38 | 7,244,740.72 |
| 无形资产 | 52,616,227.49 | 53,020,898.1 | 53,512,130.05 | 62,730,720.25 |
| 长期待摊费用 | 150,294.76 | 195,565.9 | 246,234.94 | 299,603.98 |
| 递延所得税资产 | 10,132,001.07 | 7,995,898.39 | 5,727,088.96 | 5,264,809.41 |
| 其他非流动资产 | 19,729,570.62 | 16,825,184.74 | 8,616,780 | 4,641,260 |
| 非流动资产合计 | 1,316,119,154.18 | 1,306,857,834.73 | 1,295,415,506.36 | 1,306,257,071.94 |
| 资产总计 | 1,780,431,328.37 | 1,702,348,884.14 | 1,691,594,997.68 | 1,695,205,858.12 |
| 流动负债: | | | | |
| 短期借款 | 15,003,590.28 | 15,011,840.28 | 55,095,534.72 | 55,096,333.33 |
| 应付票据及应付账款 | 43,624,441.87 | 53,690,502.13 | 49,890,303.32 | 54,707,241.06 |
| 其中：应付票据 | 5,140,000 | 140,000 | - | 1,017,200 |
| 应付账款 | 38,484,441.87 | 53,550,502.13 | 49,890,303.32 | 53,690,041.06 |
| 合同负债 | 19,179,968.54 | 7,591,826.11 | 8,530,345.02 | 10,769,510.86 |
| 应付职工薪酬 | 22,166,971.52 | 28,382,063.07 | 13,821,079.55 | 11,608,441.22 |
| 应交税费 | 30,467,951.64 | 28,786,643.25 | 17,900,057.26 | 26,010,169.81 |
| 其他应付款合计 | 116,881,876.06 | 115,226,920.15 | 125,608,730.26 | 62,275,835.78 |
| 一年内到期的非流动负债 | 17,047,835.42 | 17,043,411.99 | 3,062,533.84 | 32,934,391.6 |
| 其他流动负债 | 1,763,441.68 | 600,960.78 | 1,085,002.45 | 1,375,462.58 |
| 流动负债合计 | 266,136,077.01 | 266,334,167.76 | 274,993,586.42 | 254,777,386.24 |
| 非流动负债: | | | | |
| 长期借款 | 23,004,865.69 | 5,696,975.96 | 58,608,000 | 119,758,000 |
| 递延收益 | 21,124,973.52 | 20,420,212.5 | 16,598,631.32 | 17,304,221.62 |
| 递延所得税负债 | 11,693,702.11 | 12,102,156.88 | 12,510,611.65 | 12,919,066.4 |
| 非流动负债合计 | 55,823,541.32 | 38,219,345.34 | 87,717,242.97 | 149,981,288.02 |
| 负债合计 | 321,959,618.33 | 304,553,513.1 | 362,710,829.39 | 404,758,674.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 327,304,320 | 327,304,320 | 327,304,320 | 327,304,320 |
| 资本公积 | 154,759,519.56 | 138,706,951.38 | 122,654,383.22 | 142,998,487.16 |
| 减:库存股 | 48,286,356 | 48,286,356 | 48,286,356 | 76,397,831.64 |
| 盈余公积 | 152,704,393.13 | 152,704,393.13 | 138,586,838.77 | 138,586,838.77 |
| 未分配利润 | 864,325,502.24 | 820,035,756.79 | 781,760,120.8 | 751,460,213.24 |
| 归属于母公司股东权益合计 | 1,450,807,378.93 | 1,390,465,065.3 | 1,322,019,306.79 | 1,283,952,027.53 |
| 少数股东权益 | 7,664,331.11 | 7,330,305.74 | 6,864,861.5 | 6,495,156.33 |
| 股东权益合计 | 1,458,471,710.04 | 1,397,795,371.04 | 1,328,884,168.29 | 1,290,447,183.86 |
| 负债和股东权益合计 | 1,780,431,328.37 | 1,702,348,884.14 | 1,691,594,997.68 | 1,695,205,858.12 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-28 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |